Oncology specialists from UC San Francisco present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, May 30 to June 3 in Chicago.
In this exclusive interview with GI Oncology Now, Dr. Venook reflects on how his leadership roles have shaped his collaborative approach to cancer research and treatment.
Latest UCSF-led research establishes new neighborhood characteristics that contribute to higher death rates in children with Acute lymphoblastic leukemia (ALL) one of the most common pediatric cancers and among the leading causes of death in children.
UCSF experts highlight leadership in innovative cancer research and education at this year’s annual meeting of the American Association for Cancer Research (AACR) conference.
Davide Ruggero, PhD, professor of urology at UCSF and member of the Helen Diller Family Comprehensive Cancer Center, has received a rare renewal of his American Cancer Society (ACS) Professorship – one of the most prestigious and selective honors in cancer research.
Zotatifin, which was developed by UCSF researchers, is being tested against breast cancer. They think it also might work against prostate and other cancers.
Oncology nurse Julie McCluggage is the first nurse in UCSF history to earn the rigorous Clinical Research Nurse-Board Certified (CRN-BC) credential. McCluggage, RN, OCN, CRN-BC, has been caring for UCSF patients for 29 years.
Researchers at every UC campus and five comprehensive cancer centers are pushing cancer research in bold new directions and extending life-saving treatments and prevention strategies to more people who need them. But the nation’s bedrock source of public funding for biomedical research is under attack.
This week, UCSF lost a cherished friend and colleague with the passing of Felix Feng, MD. His legacy will live on through the many lives he touched and the impact of his work.
